Clinical Trial Update: Study of XL999 in Adults With Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study of XL999 in adults with solid tumors has completed. The update is sourced from ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• XL999

Snippet

Sponsor: Symphony Evolution, Inc. | Conditions: Cancer | Phase 1 | Status: COMPLETED